News & Events

Home > News & Events

News & Events

Press Releases

In the News

Events

2017

Medial EarlySign Machine Learning Algorithm Predicts Risk for Prediabetics Becoming Diabetic Within 1 year
Nov 01, 2017

  With No Standards in Place Today, Research May Offer New Opportunities for Care Managers to Improve Resource Allocation and Planning Methods   KFAR MALAL, Israel – November 1, 2017 – Medial EarlySign (earlysign.com), a developer of machine learning tools for data-driven medicine, today announced the results of its clinical data study on identifying and […] Read More >

New Clinical Data Research Confirms Medial EarlySign’s Machine Learning Platform Can Identify Patients at High-Risk for Colorectal Cancer
Oct 02, 2017

Results of First US-Based clinical data study of Company’s Risk Stratification Model Reveals Significant Odds Ratio Between ColonFlagTM and CRC Diagnosis   KFAR MALAL, Israel – October 2, 2017 – Medial EarlySign (www.earlysign.com), a developer of machine learning tools for data-driven medicine, today announced the results of new research in collaboration with a top integrated […] Read More >

New Clinical Data Research from Oxford University Provides Further Validation of Medial EarlySign’s Algorithm Platform for Identifying Risk of Colorectal Cancer
Sep 25, 2017

UK-Based Study Shows ColonFlagTM Stratifies Individuals According to Colorectal Cancer Risk and Could Support Earlier Detection for Improved Prognosis KFAR MALAL, Israel – September 25, 2017 – Medial EarlySign (www.earlysign.com), a developer of machine learning tools for data-driven medicine, today announced the results of new research with Oxford University. The study provides further validation for […] Read More >

Medial EarlySign Partners with Medicover on New EU Pilot Project to Identify Patients at Risk of Harboring Colorectal Cancer
Jun 27, 2017

ColonFlag Assists with Diagnostic Decision-making, Based on Applying Advanced AI to Existing EHR Data    KFAR MALAL, Israel – June 27, 2017 – Medial EarlySign (earlysign.com), a developer of machine learning tools for data driven medicine, today announced a strategic collaboration with Medicover, a leading international healthcare and diagnostic services provider, to identify individuals at […] Read More >

Medial EarlySign Named a Gartner Cool Vendor in AI for Healthcare
Jun 13, 2017

Recognition Comes on Heels of Successful Implementation of Company’s Algorithmic Platform to Identify Individuals with a High Risk of Harboring Lower GI Disorders                                          KFAR MALAL, Israel – June 13, 2017 – Medial EarlySign, a developer of machine learning tools for data driven medicine, announced today that it was selected by Gartner as a Cool […] Read More >

Medial EarlySign Awarded Horizon 2020 Seal of Excellence
Jun 07, 2017

The European Commission awarded Medial EarlySign the Horizon 2020 Seal of Excellence for the company’s Algo-Analyzer and ColonFlag tools.  The Seal of Excellence is a quality label which identifies promising project proposals which merit funding from alternative sources (public or private), i.e. national, regional, European or international.   Horizon 2020 is the biggest EU Research and Innovation […] Read More >

Maccabi & Medial EarlySign Win Bio-IT World 2017 Best Practices Award
May 29, 2017

Bio-IT World announced the winners of the 2017 Best Practices Awards at the Bio-IT World Conference and Expo on May 25th.   Maccabi Healthcare System, nominated by Medial EarlySign, won the Clinical IT & Precision Medicine category for use of ColonFlag to identify high-risk, under-the-radar patients.   Since 2003, the Bio-IT World Best Practices Awards has […] Read More >

Medial EarlySign to Present at Leading Healthcare Events on Combining AI with Existing Medical Data to Identify Individuals at Highest Risk of Disease
May 16, 2017

Presentations Will Discuss Application of Machine Learning and Big Data to Improve Population Health   KFAR MALAL, Israel – May 16, 2017 – Medial EarlySign (www.earlysign.com), a developer of machine learning tools for data driven medicine, today announced that company executives will be presenting at two upcoming leading industry events in Boston, Massachusetts: the Medical […] Read More >

Video: EarlySign Presents ColonFlag at the European Parliament
Apr 20, 2017

Medial EarlySign was recently invited to address the Members Against Cancer Group meeting at the European Parliament. Hanan Drobiner, Director of EU Operations for Medial Early Sign, explained how EarlySign’s ColonFlag solution applies machine learning algorithms to existing medical data to identify patients at high risk of harbouring colorectal cancer. The technology can provide physicians […] Read More >

New Performance Analysis Research Shows Medial EarlySign’s Machine Learning Flagging System Helps Identify Individuals at High Risk for Colorectal Cancer
Mar 07, 2017

Peer-Reviewed Study with Maccabi Health Services Shows Significant Odds Ratio between ColonFlag Tool and CRC Diagnosis     KFAR MALAL, Israel – March 7, 2017 – Medial EarlySign (www.earlysign.com), a developer of machine learning tools for data driven medicine, today announced new research with one of Israel’s leading integrated delivery networks, Maccabi Health Services (MHS), […] Read More >

Medial EarlySign Enables Leading Israeli HMO to Identify Pre-Symptomatic Patients at High Risk for Cancer
Feb 28, 2017

Developer of Predictive Care Engine Collaborates with Maccabi Healthcare Services to Forecast Likelihood of Colorectal Cancer in General Population     KFAR MALAL, Israel – February 28, 2017 – Medial EarlySign (earlysign.com), a developer of machine learning tools for data driven medicine, today announced first-year results of  its implementation with Maccabi Healthcare Services (MHS), for […] Read More >
2017
Upcoming Events

Medial EarlySign at AMIA 2017 Annual Symposium
November 04 - 08, 2017

The AMIA Annual Symposium actively supports research and practice in the five domains in informatics: translational bioinformatics, clinical research informatics, clinical informatics, consumer health informatics, and public health informatics.  The symposium will take place on November 4 – 8, 2017 in Washington, DC.   Please contact us to set up a meeting to learn about our work. Read More >

Medial EarlySign CEO Selected to Present at Credit Suisse’s 4th Private Innovation Circle
December 11, 2017

Medial EarlySign CEO, Ori Geva, has been selected to present at Credit Suisse’s 4th Private Innovation Circle, an event focused on bringing investors and entrepreneurs together for targeted investment opportunities.   The 4th Private Innovation Circle builds on the initiative’s success over the last three years, while focusing on further enhancing the matchmaking potential of the platform […] Read More >

Medial EarlySign CEO to Present at Molecular Medicine Tri-Conference
February 11-16, 2018

The Molecular Medicine Tri-Conference brings together thought leaders in the fields of drug discovery, development and diagnostics.  The conference will take place February 11-16, 2018 in San Francisco, CA. Medial EarlySign CEO, Ori Geva, will present on Monday, February 12 on the panel SC20: Best Practices in Personalized and Translational Medicine. Please contact us to set up a […] Read More >

Medial EarlySign to Exhibit at HIMSS 2018
March 5-9, 2018

Medial EarlySign will be exhibiting at Booth #8104.   The 2018 HIMSS Annual Conference & Exhibition, March 5-9, 2018 in Las Vegas, brings together 40,000+ health IT professionals, clinicians, executives and vendors from around the world. Exceptional education, world-class speakers, cutting-edge health IT products and powerful networking are hallmarks of this industry-leading conference.    Please contact us to set […] Read More >

Eighteenth Population Health Colloquium
March 19-21, 2018

The leading forum on population health and policy produced by GHC taking place in Philadelphia, PA on March 19-21, 2018. Please contact us to set up a meeting to learn about our work in population health. Read More >

Ori Geva, CEO of Medial EarlySign, to Present at Venture Beat Summit 2017
October 24, 2017

VB Summit 2017 is an invitation-only executive event, focusing on the explosion of AI in business – specifically how executives are using AI to extract real ROI for their companies.   Ori Geva, Medial EarlySign’s CEO, will be presenting at this sold out summit on how new AI technology is rapidly transforming healthcare for the […] Read More >

Ori Geva, CEO of Medial EarlySign, to Present at Singularity University
October 26, 2017

SingularityU Chapter is a local community-driven group working collaboratively with Singularity University and focuses on the challenges which Poland, and specifically Warsaw, face.  Main areas of focus are: healthcare, FinTech, fashion, space, energy, transport, sustainability and education.  Medial EarlySign co-founder and CEO Ori Geva will speak at the Chapter’s conference on October 26 in Warsaw, […] Read More >

NCT Heidelberg – 3rd International Symposium: “Innovations in Oncology”
June 26-27, 2017

Hosted by the National Center for Tumor Diseases (NCT) Heidelberg, the German Cancer Research Center (DKFZ), the Heidelberg University Hospital , the Felix Burda Foundation, the German Network against Colorectal Cancer and in cooperation with the German Cancer Society (DKG) the 3rd International Symposium: “Innovations in Oncology” will bring together scientists and physicians from academics […] Read More >

2017 Digestive Disease Week (DDW)
May 06-09, 2017

DDW is the annual meeting for professionals in the field of Gastroenterology, Endoscopy, Hepatology, Digestive System and Gastrointestinal Surgery.  DDW 2017 is the one of the biggest events and organized annually. There are more than 14000 attendee will participate in this meeting in this year.   To set up a meeting with us during the week please […] Read More >

2017 Dialogue for Action® On Cancer Screening & Prevention
April 19-21, 2017

This will be Prevent Cancer Foundation’s nineteenth annual Dialogue for Action®. This year’s planned topics include: social determinants of health; key legislation; prevention initiatives to reduce health disparities; research trends and advancements in cancer prevention and early detection; developments in imaging for cancer screening; the Precision Medicine Initiative; updates on screening guidelines; global prevention and […] Read More >

Ca-PRI 10-Year Anniversary Conference
April 18 – 20, 2017

Medial EarlySign will be at the Ca-PRI 2017 conference to present the results of the implementation of ColonFlag, EarlySign’s machine learning platform, with one of the world’s leading health maintenance organizations.   In a presentation titled Live implementation of ColonFlag as an adjunct for population management allowing practitioners to identify non-compliant individuals at risk of […] Read More >

MedinIsrael 2017 – Dr. Bożena Walewska-Zielecka to Present Medicover’s ColonFlag Implementation
March 6-9, 2017

MEDinISRAEL 2017 is initiated and organized by The Israel Export Institute in cooperation with the Ministry of Economy and Industry, the Ministry of Health and the Ministry of Foreign Affairs, with over 500 Israeli medical device exporters who are actively engaged in a broad variety of medical applications.   Dr. Bożena Walewska-Zielecka is the Deputy Director […] Read More >

HIMSS 2017
February 19–23, 2017

The 2017 HIMSS Annual Conference & Exhibition, February 19–23, 2017 in Orlando, brings together 40,000+ health IT professionals, clinicians, executives and vendors from around the world. Exceptional education, world-class speakers, cutting-edge health IT products and powerful networking are hallmarks of this industry-leading conference. More than 300 education programs feature keynotes, thought leader sessions, roundtable discussions […] Read More >

Ori Geva to Present at the Digital Medicine Showcase
Jan 11th 2017

Ori Geva, Medial EarlSign’s CEO will be presenting at the Digital Medicine Showcase in San Francisco. For more information, please see here:   Read More >
Past Events

Big Data in Precision Medicine
Nov. 1-2, 2016

Dr. Ran Goshen, Medial EarlySign’s CMO will be presenting the potential impact of Machine Learning technologies on Precision Medicine.  Dr. Goshen will illustrate the use in clinical practice of EarlySign’s MeScore CRC at Maccabi Healthcare (MHS) and review initial results for prediction of renal deterioration. Read More >

European Digital Health Day 2016
April 28th, 2016

The conference aims to connect European digital health innovators with invitation-only healthcare stakeholders.   Medial EarlySign was one of 6 companies that were invited along with companies from Germany, Spain and UK.  Subjects this year spanned virtual reality, smartphone, big data analytics and artificial intelligence solutions for disease prevention, detection, monitoring and treatment.   Dr. Arturo […] Read More >

DDW 2016
May 21 - May 24, 2016

Read More >